Answers are grounded in this paper and cite their sources.
Panax notoginseng has long attracted attention for its diverse pharmacological activities. Saponins, the primary bioactive constituents of P. notoginseng , hold significant potential for industrial production and application. However, their biosynthesis, particularly the multi‑site oxidation steps catalyzed by cytochrome P450 (CYP450) enzymes and the associated regulatory mechanisms, remains poorly understood, hindering further development in this field. In this study, we integrated existing genomic and transcriptomic data of P. notoginseng to systematically analyze 297 PnCYP450 genes. Expression profiling under different nitrogen treatments revealed distinct response patterns, with 17 genes exhibiting significant differential expression. Through phylogenetic and functional analyses with known triterpenoid saponin‑related CYP450s from diverse species, five genes ( PnCYP7 , PnCYP141 , PnCYP188 , PnCYP264 , and PnCYP266 ) were identified as strong candidates involved in the oxidative modification of saponins in P. notoginseng . Molecular docking simulations further supported their predicted functions: PnCYP141 and PnCYP266 exhibited favorable interactions with dammarane‑type saponin precursors, while PnCYP7, PnCYP188, and PnCYP264 showed binding affinities consistent with roles in oleanane‑type saponin biosynthesis. Additionally, we screened for transcription factors potentially regulating these candidate genes and constructed a preliminary regulatory network. Collectively, our findings provide both theoretical and experimental foundations for elucidating the biosynthetic pathway and regulatory mechanisms of saponins in P. notoginseng , and offer insights into the quality formation of medicinal materials within the Panax genus.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: